ArticleInternational journal of general medicine2025
The Value of NLR and PLR in the Diagnosis of Rheumatoid Arthritis Combined with Interstitial Lung Disease and Assessment of Treatment Effect: A Retrospective Cohort Study.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Red Cell Distribution Width to Albumin Ratio: A Novel and Potential Biomarker for Rheumatoid Arthritis.Journal of inflammation research · 2026Article
- Nonlinear Relationship of Leukocyte-to-Albumin Ratio with Disease Activity in Rheumatoid Arthritis.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This retrospective cohort study investigated the value of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in the diagnosis and treatment of rheumatoid arthritis complicated with interstitial lung disease (RA-ILD). Methods: A total of 163 patients with newly diagnosed rheumatoid arthritis (RA) were enrolled, with 122 patients in the RA group and 41 patients in the RA-ILD group. The mean age of the RA group was 63.84 ± 8.53 years, with a male-to-female ratio of 14:47. The RA-ILD group had a mean age of 66.29 ± 12.72 years, with a male-to-female ratio of 13:28. During the 2-year follow-up period, 10 patients in the RA group developed interstitial lung disease (ILD). Results: NLR and PLR were significantly higher in RA-ILD group than in RA group (p < 0.05). The optimal critical values of NLR and PLR for the diagnosis of RA-ILD were 3.15 and 152.62, the area under ROC curve was 0.615 and 0.61, the sensitivity was 72%, 62%, and the specificity was 54% and 64%. NLR and PLR were significantly increased after ILD during follow-up in RA patients but decreased after ILD in the predicted percentage of vital capacity (VC%), forced vital capacity (FVC%), forced expiratory volume in the first second (FEV1%) and carbon monoxide dispersion (DLcoSB%) (p < 0.05). Moreover, NLR and PLR decreased after treatment. While VC%, FVC%, FEV1%, and DLcoSB% increased after treatment (p < 0.05). NLR was negatively correlated with FVC% and DLcoSB% both before and after treatment. PLR was also significantly negatively correlated with FVC% and DLcoSB% before and after treatment (p < 0.05). Conclusion: When NLR and PLR increase, we should be alert to the possibility of RA complicated with ILD, which can be used as an evaluation index of the treatment effect of RA-ILD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.